Andrea Oliva

Andrea Oliva is the Head of Pharmacovigilance at Mylan and he was Graduated in Milan in Pharmaceutical Biotechnology and in Biology Applied to Biomedical Research, he worked for two years as a researcher in the field of infectious diseases at the L. Sacco Hospital. From 2009 he starts in the technical/scientific management team as a pharmacovigilance contact person for Teofarma.

After a brief period of study in DOC Generici, he moves to counsel, where he is responsible for the coordination of post-marketing pharmacovigilance activities as well as clinical research, also taking on the role of QPPV for different companies. In the last period as a consultant, he has also been involved in the coordination of the Regulatory Affairs office. Until June 2017 he was responsible for pharmacovigilance in Boehringer Ingelheim Italy and recently took over the role of Head of Pharmacovigilance for Mylan Spa.